\-\ Texto\\:\\ \ \(0\)\
\-\ obtunded\\ \ \(4\)\
\-\ no\\ focal\\ signs\\ or\\ symptoms\ \(0\)\
\-\ patient\\'s\\ mental\\ status\\ improved\\ on\\ antifungal\\ medications\\.\ \(0\)\
\-\ \\â\\€\\¢\\ high\\ signal\\ t1\\ lesions\\ in\\ the\\ perivascular\\ spaces\\ bilateral\\ basal\\ ganglia\ \(0\)\
\-\ \\â\\€\\¢\\ lesions\\ enhance\\ following\\ contrast\\ administration\ \(0\)\
\-\ \\â\\€\\¢\\ minimal\\ mass\\ effect\ \(0\)\
\-\ cryptococcus\\,\\ cryptococcoma\\ \\(presumed\\)\ \(0\)\
\-\ \\â\\€\\¢\\ cryptococcus\\ meningitis\ \(0\)\
\-\ \\â\\€\\¢\\ toxoplasmosis\ \(0\)\
\-\ \\â\\€\\¢\\ hemorrhage\ \(2\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ 39\\ year\\ old\\ woman\\ s\\/p\\ bone\\ marrow\\ transplant\\ therapy\\ for\\ leukemia\\.\\ \\ decrease\\ in\\ mental\\ status\\ prompted\\ mri\\.\ \(0\)\
\-\ in\\ spite\\ of\\ brain\\ biopsy\\ and\\ multiple\\ csf\\ and\\ blood\\ samples\\ cryptococcus\\ could\\ not\\ be\\ confirmed\\.\\ \\ the\\ cause\\ of\\ the\\ high\\ signal\\ intensity\\ lesions\\ in\\ the\\ vr\\ spaces\\ is\\ likely\\ to\\ be\\ due\\ to\\ proteinaceous\\ fluid\\ in\\ the\\ pseuocapsule\\ of\\ the\\ offending\\ organism\\ \\-\\ since\\ neither\\ calcium\\ nor\\ blood\\ was\\ demonstrated\\ in\\ these\\ regions\\ on\\ a\\ contemporary\\ ct\\ scan\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cryptococcus\\:\\ 0\\.15194158381097733\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.0824744395576783\ \(0\)\
\-\ pseuocapsule\\:\\ 0\\.06628209341328194\ \(0\)\
\-\ spaces\\:\\ 0\\.06331350733802114\ \(0\)\
\-\ cryptococcoma\\:\\ 0\\.061070460476740994\ \(0\)\
\-\ mental\\:\\ 0\\.05995796521299544\ \(0\)\
\-\ vr\\:\\ 0\\.058021850641341265\ \(0\)\
\-\ spite\\:\\ 0\\.0541810564776872\ \(0\)\
\-\ antifungal\\:\\ 0\\.05281021770480032\ \(0\)\
\-\ contemporary\\:\\ 0\\.05281021770480032\ \(0\)\
\-\ samples\\:\\ 0\\.0516511900369262\ \(0\)\
\-\ lesions\\:\\ 0\\.051599109165652954\ \(0\)\
\-\ offending\\:\\ 0\\.04896942354114626\ \(0\)\
\-\ proteinaceous\\:\\ 0\\.04592081370574652\ \(0\)\
\-\ status\\:\\ 0\\.04586958377716772\ \(0\)\
\-\ obtunded\\:\\ 0\\.045435561667118166\ \(0\)\
\-\ organism\\:\\ 0\\.04414345447218088\ \(0\)\
\-\ perivascular\\:\\ 0\\.043757790604605315\ \(0\)\
\-\ neither\\:\\ 0\\.04304117271133971\ \(0\)\
\-\ toxoplasmosis\\:\\ 0\\.04122792416384431\ \(0\)\
\-\ prompted\\:\\ 0\\.03999256287593998\ \(0\)\
\-\ presumed\\:\\ 0\\.03643027451439381\ \(0\)\
\-\ transplant\\:\\ 0\\.03549754783266464\ \(0\)\
\-\ high\\:\\ 0\\.035166106181606246\ \(0\)\
\-\ blood\\:\\ 0\\.03507385071442556\ \(0\)\
\-\ nor\\:\\ 0\\.03433852016479052\ \(0\)\
\-\ signal\\:\\ 0\\.03388081699658314\ \(0\)\
\-\ meningitis\\:\\ 0\\.03333452473152343\ \(0\)\
\-\ leukemia\\:\\ 0\\.03296768139190364\ \(0\)\
\-\ ganglia\\:\\ 0\\.03287870050733971\ \(0\)\
\-\ calcium\\:\\ 0\\.031434507035615504\ \(0\)\
\-\ enhance\\:\\ 0\\.03107809922437803\ \(0\)\
\-\ improved\\:\\ 0\\.030605911997016903\ \(0\)\
\-\ 39\\:\\ 0\\.029859634116600805\ \(0\)\
\-\ decrease\\:\\ 0\\.029400328161865177\ \(0\)\
\-\ regions\\:\\ 0\\.029400328161865177\ \(0\)\
\-\ basal\\:\\ 0\\.02928975562510055\ \(0\)\
\-\ medications\\:\\ 0\\.028658436977601797\ \(0\)\
\-\ marrow\\:\\ 0\\.028265207658783383\ \(0\)\
\-\ s\\/p\\:\\ 0\\.026950449677533166\ \(0\)\
\-\ csf\\:\\ 0\\.026830784600045204\ \(0\)\
\-\ administration\\:\\ 0\\.02667413733009902\ \(0\)\
\-\ minimal\\:\\ 0\\.025296841882712764\ \(0\)\
\-\ confirmed\\:\\ 0\\.024160899271329302\ \(0\)\
\-\ could\\:\\ 0\\.02370344318669588\ \(0\)\
\-\ since\\:\\ 0\\.02359973399773095\ \(0\)\
\-\ intensity\\:\\ 0\\.02322308779232557\ \(0\)\
\-\ biopsy\\:\\ 0\\.022794686027344063\ \(0\)\
\-\ effect\\:\\ 0\\.022748558293753718\ \(0\)\
\-\ signs\\:\\ 0\\.022611849127714693\ \(0\)\
\-\ cause\\:\\ 0\\.021738816740992224\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.021385387850947634\ \(0\)\
\-\ t1\\:\\ 0\\.020364628091911606\ \(0\)\
\-\ be\\:\\ 0\\.019815890576600437\ \(0\)\
\-\ brain\\:\\ 0\\.019333470100020764\ \(0\)\
\-\ in\\:\\ 0\\.019010401359710747\ \(0\)\
\-\ demonstrated\\:\\ 0\\.018852781822984718\ \(0\)\
\-\ focal\\:\\ 0\\.018349575970965426\ \(0\)\
\-\ fluid\\:\\ 0\\.018260444395517692\ \(0\)\
\-\ following\\:\\ 0\\.01823517110451991\ \(0\)\
\-\ likely\\:\\ 0\\.018122480946884633\ \(0\)\
\-\ scan\\:\\ 0\\.01798700346190209\ \(0\)\
\-\ therapy\\:\\ 0\\.01717775034767378\ \(0\)\
\-\ due\\:\\ 0\\.01714494099964541\ \(0\)\
\-\ these\\:\\ 0\\.016720636781637894\ \(0\)\
\-\ metastatic\\:\\ 0\\.01617375491440669\ \(0\)\
\-\ symptoms\\:\\ 0\\.016012462232316834\ \(0\)\
\-\ bone\\:\\ 0\\.01596567429669075\ \(0\)\
\-\ bilateral\\:\\ 0\\.015592614506123637\ \(0\)\
\-\ woman\\:\\ 0\\.01484137554502937\ \(0\)\
\-\ mri\\:\\ 0\\.014761472593343006\ \(0\)\
\-\ contrast\\:\\ 0\\.014381772081262446\ \(0\)\
\-\ \\'s\\:\\ 0\\.014165764047872518\ \(0\)\
\-\ \\-\\:\\ 0\\.013772394426378672\ \(0\)\
\-\ multiple\\:\\ 0\\.013532375966009539\ \(0\)\
\-\ on\\:\\ 0\\.010885579133314708\ \(0\)\
\-\ disease\\:\\ 0\\.010501786024178226\ \(0\)\
\-\ not\\:\\ 0\\.009284350915352898\ \(0\)\
\-\ ct\\:\\ 0\\.008987245514225885\ \(0\)\
\-\ mass\\:\\ 0\\.00893579704471853\ \(0\)\
\-\ or\\:\\ 0\\.00753024623280983\ \(0\)\
\-\ was\\:\\ 0\\.007430658061757044\ \(0\)\
\-\ year\\:\\ 0\\.007188761423104622\ \(0\)\
\-\ old\\:\\ 0\\.006578455615505674\ \(0\)\
\-\ no\\:\\ 0\\.006469504892509789\ \(0\)\
\-\ patient\\:\\ 0\\.006440540833957804\ \(0\)\
\-\ to\\:\\ 0\\.006422076818691522\ \(0\)\
\-\ the\\:\\ 0\\.006236809836253795\ \(0\)\
\-\ for\\:\\ 0\\.005482016155208384\ \(0\)\
\-\ \\(\\:\\ 0\\.005431291174765868\ \(0\)\
\-\ \\)\\:\\ 0\\.005364945053483497\ \(0\)\
\-\ is\\:\\ 0\\.00422775021341899\ \(0\)\
\-\ a\\:\\ 0\\.0029819533971323403\ \(0\)\
\-\ and\\:\\ 0\\.002706902341837871\ \(0\)\
\-\ of\\:\\ 0\\.0026279052811576335\ \(0\)\
\-\ \\,\\:\\ 0\\.0020354140264457698\ \(0\)\
\-\ \\.\\:\\ 0\\.0013345690262160253\ \(0\)\
